Scarica l'app Stockscreener
1.35
2.88%
-0.04
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché OPK Giù?
Forum
Previsione
Opko Health Inc Borsa (OPK) Ultime notizie
Here's why you should retain OPK stock in your portfolio for now - MSN
OPKOpko Health Inc Options - Finviz
OPKO Health Inc focuses on diagnostics and pharmaceuticals as investors weigh long-term prospects - ad-hoc-news.de
Form 13D/A OPKO HEALTH For: 1 July By Investing.com - Investing.com UK
Phillip Frost (NASDAQ: OPK) reports 34.1% beneficial stake in OPKO - Stock Titan
OPKO Health (OPK) up 17.1% since last earnings report: Can it continue? - MSN
ETFs Investing in OPKO Health, Inc. Stocks - TradingView
XCY Forecast — Price Target — Prediction for 2027 - TradingView
OPKO Health, Inc. Actuals & Estimates (BMV:OPK) - TradingView
Price to sales forward of Opko Health, Inc. – NASDAQ:OPK - TradingView
Opko Health stock hits 52-week high at 1.6 USD By Investing.com - Investing.com South Africa
Enterprise value to EBITDA forward of Opko Health, Inc. – NASDAQ:OPK - TradingView
Price to book forward of OPKO Health, Inc. – FWB:XCY - TradingView
Price to earnings forward of OPKO Health, Inc. – FWB:XCY - TradingView
Enterprise value to EBIT forward of Opko Health, Inc. – NASDAQ:OPK - TradingView
Enterprise value to EBIT forward of OPKO Health, Inc. – FWB:XCY - TradingView
OPKO Health, Inc. Actuals & Estimates (NASDAQ:OPK) - TradingView
OPKO Health, Inc. Actuals & Estimates (BX:XCY) - TradingView
OPKO Health, Inc. Actuals & Estimates (FWB:XCY) - TradingView
OPKO Health, Inc. Actuals & Estimates (TASE:OPK) - TradingView
OPK Forecast — Price Target — Prediction for 2027 - TradingView
OPKO Health (OPK) Stock Could Be 57% Undervalued As Margin Recovery Comes Into Focus - Sahm
OPKO Health Inc (OPK) Institutional Confidence - TradingKey
OPKO Health (OPK) Hovers Near Key Resistance Amid Modest GainsPrice Momentum Stocks - dars.gov.et
OPKO Health (OPK) Edges Higher as Traders Eye Key Resistance LevelMFI Overbought - dars.gov.et
Form 4 Opko Health For: 22 June By Investing.com - Investing.com Nigeria
Director at OPKO (NASDAQ: OPK) receives grant of 60,000 stock options - Stock Titan
OPKO Health (OPK) director receives 30,000-share stock option award at $1.42 - Stock Titan
Opko Health (OPK) director Roger Medel receives 30,000 stock options grant - Stock Titan
Opko Health (OPK) director awarded 30,000 stock options at $1.42 strike - Stock Titan
OPKO Health (OPK) director receives stock options for 30,000 shares - Stock Titan
OPKO HEALTH (OPK) director receives 80,000-share stock option grant - Stock Titan
Opko Health Shareholders Back Board, Equity and Auditors - The Globe and Mail
Opko Health shareholders elect board and approve key proposals at annual meeting - Investing.com
OPKO Health (OPK) AGM 2026 Summary - Quartr
OPK: All proposals passed, with robust pipeline progress and $98M remaining for share repurchases - TradingView
OPKO Health Inc (OPK) Valuation: PE, PB & Fair Value Analysis - TradingKey
OPK: All proposals passed; clinical pipeline and cash flow strong; $98M buyback authorization remains - TradingView
OPKO Health Inc (OPK) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
OPKO Health Inc (OPK) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
OPKO Health Inc (OPK) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
OPKO Health Inc (OPK) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
OPKO Health Inc (OPK) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
OPKO Health Inc (OPK) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
OPKO Health Inc (OPK) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Piper Sandler Maintains Opko Health(OPK.US) With Buy Rating, Maintains Target Price $3 - Moomoo
Piper Sandler Sticks to Their Buy Rating for Opko Health (OPK) - The Globe and Mail
OPKO Health (OPK) Stock Could Be 58.8% Undervalued After OPK8801001 Preclinical Update - Sahm
OPKO presents preclinical data on acromegaly drug candidate By Investing.com - Investing.com Australia
OPKO presents preclinical data on acromegaly drug candidate - Investing.com
Preclinical Data for OPKO Biologics' OPK8801001 in Acromegaly Presented at ENDO 2026 - The Manila Times
0.29%
0.63%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):